Antiapoptotic effects of the peptidergic drug Cerebrolysin on primary cultures of embryonic chick cortical neurons

被引:91
作者
Hartbauer, M
Hutter-Paier, B
Skofitsch, G
Windisch, M
机构
[1] Karl Franzens Univ, Dept Neurobiol, Inst Zool, A-8010 Graz, Austria
[2] Inst Expt Pharmacol Res Initiat EBEWE, Graz, Austria
[3] Karl Franzens Univ Graz, Inst Zool, Dept Histopharmacol, Graz, Austria
关键词
cerebrolysin; growth factors; apoptosis; chick neuron; neuroprotection; serum supplement;
D O I
10.1007/s007020170067
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cerebrolysin (EBEWE Arzneimittel, Austria, Europe) is a widely used drug relieving the symptoms of a variety of neurological disorders, particularly of neurodegenerative dementia of the Alzheimer's type. It consists of approximately 25% of low molecular weight peptides (<10 k DA) and a mixture of approximately 75% free amino acids, this being based on the total nitrogen content. In this study we used a low serum (2% serum supplement) cell stress in-vitro model to assess drug effectiveness on neuronal viability and programmed cell death (PCD). In this in-vitro model the type of cell death was previously shown to be primarly apoptotic, which was verified by DNA-laddering and TUNEL-staining. For evaluation of neuronal viability a MTT-reduction assay was performed after 4 DIV and 8 DIV and the percentage of apoptotic neurons was determined by bis-benzimide staining of nuclear chromatin. To differentiate between possible effects of the free amino acids and the peptide fraction of Cerebrolysin an artificial amino acid mixture (AA-mix) was used as a control. Cerebrolysin, the AA-mix and 10% foetal calf serum (FCS) caused a similar increase in viability after 4 DIV, whereas the effects of the growth factors BDNF and FGF-2 were less pronounced. After 8 DIV Cerebrolysin, but not the AA-mix, was able to ameliorate neuronal viability, which could reflect a neuro-protective effect or an increased activity of the mitochondrial dehydrogenase measured in a MTT-reduction assay. The percentage of cells showing apoptotic chromatin changes was significantly reduced (p < 0.01) in cultures treated with Cerebrolysin, whereas the AA-mix failed to decrease the percentage of cells showing apoptotic chromatin changes. These findings ascertain an anti-apoptotic effect of the peptide fraction of Cerebrolysin and reveal a transient viability promoting effect of the amino acid fraction, which is most likely due to improved nutritional supply.
引用
收藏
页码:459 / 473
页数:15
相关论文
共 48 条
[31]   Ultrastructure of excitotoxic neuronal death in murine cortical culture [J].
Regan, RF ;
Panter, SS ;
Witz, A ;
Tilly, JL ;
Giffard, RG .
BRAIN RESEARCH, 1995, 705 (1-2) :188-198
[32]  
Reinprecht K, 1998, J NEURAL TRANSM-SUPP, P373
[33]   EFFICACY OF THE PEPTIDERGIC NOOTROPIC DRUG CEREBROLYSIN IN PATIENTS WITH SENILE DEMENTIA OF THE ALZHEIMER-TYPE (SDAT) [J].
RUTHER, E ;
RITTER, R ;
APECECHEA, M ;
FREYTAG, S ;
WINDISCH, M .
PHARMACOPSYCHIATRY, 1994, 27 (01) :32-40
[34]  
SATOU T, 1993, ADV BIOSCI, V87, P195
[35]  
SATOU T, 1994, JPN PHARMACOL THER, V22, P205
[36]  
Schwab M, 1997, EXP TOXICOL PATHOL, V49, P105
[37]   EXCITATORY AMINO-ACIDS ACTIVATE CALPAIN-I AND INDUCE STRUCTURAL PROTEIN BREAKDOWN INVIVO [J].
SIMAN, R ;
NOSZEK, JC .
NEURON, 1988, 1 (04) :279-287
[38]   Kainic acid induces apoptosis in neurons [J].
Simonian, NA ;
Getz, RL ;
Leveque, JC ;
Konradi, C ;
Coyle, JT .
NEUROSCIENCE, 1996, 75 (04) :1047-1055
[39]   CALPAIN ACTIVATION IN APOPTOSIS [J].
SQUIER, MKT ;
MILLER, ACK ;
MALKINSON, AM ;
COHEN, JJ .
JOURNAL OF CELLULAR PHYSIOLOGY, 1994, 159 (02) :229-237
[40]   Topographic associations between DNA fragmentation and Alzheimer's disease neuropathology in the hippocampus [J].
Sugaya, K ;
Reeves, M ;
McKinney, M .
NEUROCHEMISTRY INTERNATIONAL, 1997, 31 (02) :275-281